Kidney function may change how obesity drug works
NCT ID NCT07347808
First seen Jan 17, 2026 · Last updated May 13, 2026 · Updated 14 times
Summary
This study tested a single dose of VCT220 in 16 people to see how kidney function affects the drug. Half had moderate kidney problems, half had normal kidneys. The goal was to learn how to dose the drug safely for people with kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY/OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Conditions
Explore the condition pages connected to this study.